BALTIMORE, Feb. 26, 2021 /PRNewswire-PRWeb/ -- The
LaunchPort™ announced today that Novel Microdevices
(http://www.noveldx.com) has moved to their Medtech venture center
in Port Covington, Baltimore, and
has established The LaunchPort™ as its primary location for their
GMP development efforts.
Novel Microdevices has established engineering prototyping,
clean room operations, materials handling, and shop capabilities in
separate modules within the Center that are allowing them to
develop and validate the various elements of their Good
Manufacturing Processes (GMP). The Company has received over
$2M in NIH funding and is in the
process of securing additional contracts for the delivery of
diagnostics of sexually transmitted infections. The Company also
recently received funding from NIH's RADx program to explore the
possible application of their technology to COVID-19
diagnostics.
Robert Storey, Managing Partner
of The LaunchPort™, noted that cofounders Andrea and Rohan Pais have steadily built their
company from a concept over the past six years in Baltimore, drawing on significant clinical
support from the institutions in the area. The Pais' both started
their careers with SB Microsystems (Glen
Burnie, MD) an anchor of biomedical sensor development in
the Baltimore area. "This is a
power team and we're pleased that that Micro is joining us at this
exciting time in their journey. We have every expectation that they
will become an important element for the growth of diagnostics
manufacturing in the region".
About Novel Microdevices (Baltimore,
MD)
Novel Microdevices is commercializing Novel Dx, a proprietary and
best-in-class Point-of-Care (POC) rapid molecular diagnostics
system that is designed to be CLIA-waived. The Novel Dx system
includes an ultra-portable instrument and test-specific consumable
cartridges that can be produced for a wide range of high-volume
molecular diagnostic assay applications. The company is focusing on
the $31 Billion Infectious Diseases
Diagnostics Market with tests in development for multiple
respiratory and sexually transmitted infections.
About The LaunchPort™ (Port Covington, Baltimore, MD)
The LaunchPort™ (http://www.thelaunchport.com) is a Medtech venture
center that allows Medtech start-ups and emerging technology
developers the ability to co-locate at an experienced, regulated
manufacturing center. Located at the "City Garage" in Baltimore's Port Covington, it is in close
proximity to two of the Country's premier medical schools
(Johns Hopkins and University of Maryland) and at the center of one of
the world's largest urban revitalization projects.
Media Contact
Robert Storey, The LaunchPort, +1
(443) 994-2241, bstorey@mvrco.com
SOURCE The LaunchPort